Acta Med. 2014, 57: 49-55

https://doi.org/10.14712/18059694.2014.39

RADIOIODINE TREATMENT OF GRAVES’ DISEASE – DOSE/RESPONSE ANALYSIS

Jitka Čepkováa, Jiří Horáčeka, Jaroslav Vižďab, Jiří Doležalb

a4th Department of Internal Medicine – Hematology, University Hospital Hradec Králové, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic
bDepartment of Nuclear Medicine, University Hospital Hradec Králové, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic

Crossref Cited-by Linking

  • NEUMANN Regina, THOMANN Robert, GOERRES Gerhard W.: A retrospective study with long term follow-up of Graves' disease patients treated with low activities of 131Iodine. Q J Nucl Med Mol Imaging 2024, 68. <https://doi.org/10.23736/S1824-4785.22.03468-9>
  • Xiaoyin Tang, Bingwei Lu, Min Ding, Yan Lin, Ping Li, Bo Zhai: Preliminary Results of Utrasound-Guided Percutaneous Radiofrequency Ablation in the Treatment of Refractory Non-nodular Hyperthyroidism. Cardiovasc Intervent Radiol 2023, 46, 1015. <https://doi.org/10.1007/s00270-023-03401-5>
  • Tamatea Jade A. U., Conaglen John V., Elston Marianne S.: Response to Radioiodine Therapy for Thyrotoxicosis: Disparate Outcomes for an Indigenous Population. International Journal of Endocrinology 2016, 2016, 1. <https://doi.org/10.1155/2016/7863867>
Crossref Cited-by Linking logo